Diversified Healthcare Trust (NASDAQ:DHC) Reaches New 52-Week High – Should You Buy?

Diversified Healthcare Trust (NASDAQ:DHC) shares reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $5.46 and last traded at $5.3850, with a volume of 45024 shares trading hands. The stock had previously closed at $5.43.

Analysts Set New Price Targets

Several equities research analysts recently commented on DHC shares. B. Riley reissued a “buy” rating and issued a $6.50 price target (up previously from $5.50) on shares of Diversified Healthcare Trust in a research note on Monday, December 15th. Royal Bank Of Canada upgraded shares of Diversified Healthcare Trust from an “underperform” rating to a “sector perform” rating and lifted their target price for the company from $3.00 to $5.00 in a research note on Thursday, November 13th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Diversified Healthcare Trust in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Diversified Healthcare Trust has a consensus rating of “Hold” and an average target price of $5.75.

Diversified Healthcare Trust Price Performance

The company has a debt-to-equity ratio of 1.61, a current ratio of 16.89 and a quick ratio of 16.89. The stock’s 50 day moving average price is $4.88 and its two-hundred day moving average price is $4.25. The firm has a market capitalization of $1.33 billion, a price-to-earnings ratio of 26.75 and a beta of 2.42.

Diversified Healthcare Trust (NASDAQ:DHC) last announced its earnings results on Monday, November 3rd. The real estate investment trust reported $0.04 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.04). The firm had revenue of $388.71 million during the quarter, compared to the consensus estimate of $382.10 million. Diversified Healthcare Trust had a negative return on equity of 18.90% and a negative net margin of 22.90%.

Diversified Healthcare Trust Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, February 19th. Investors of record on Monday, January 26th will be given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, January 26th. Diversified Healthcare Trust’s payout ratio is currently -2.74%.

Insiders Place Their Bets

In other Diversified Healthcare Trust news, CEO Christopher J. Bilotto bought 20,000 shares of the stock in a transaction on Monday, December 15th. The shares were purchased at an average price of $4.89 per share, with a total value of $97,800.00. Following the acquisition, the chief executive officer directly owned 266,285 shares of the company’s stock, valued at $1,302,133.65. This represents a 8.12% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 1.37% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Diversified Healthcare Trust

Institutional investors and hedge funds have recently bought and sold shares of the business. Prudential Financial Inc. raised its holdings in shares of Diversified Healthcare Trust by 7.7% in the 2nd quarter. Prudential Financial Inc. now owns 2,129,197 shares of the real estate investment trust’s stock worth $7,623,000 after buying an additional 151,479 shares in the last quarter. Farther Finance Advisors LLC grew its position in Diversified Healthcare Trust by 169.2% in the second quarter. Farther Finance Advisors LLC now owns 10,161 shares of the real estate investment trust’s stock valued at $36,000 after acquiring an additional 6,387 shares during the period. Arrowstreet Capital Limited Partnership grew its position in Diversified Healthcare Trust by 22.3% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,890,628 shares of the real estate investment trust’s stock valued at $6,768,000 after acquiring an additional 345,110 shares during the period. Geode Capital Management LLC raised its stake in Diversified Healthcare Trust by 0.8% during the second quarter. Geode Capital Management LLC now owns 5,847,246 shares of the real estate investment trust’s stock worth $20,936,000 after acquiring an additional 44,759 shares in the last quarter. Finally, Carronade Capital Management LP lifted its holdings in shares of Diversified Healthcare Trust by 588.7% during the second quarter. Carronade Capital Management LP now owns 1,618,448 shares of the real estate investment trust’s stock valued at $5,794,000 after acquiring an additional 1,383,448 shares during the period. Institutional investors own 75.98% of the company’s stock.

About Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust (REIT) specializing in the acquisition, ownership and management of healthcare properties across the United States. The company focuses on assets that serve the senior housing and post-acute care sectors, including skilled nursing facilities, assisted living communities, memory care centers and medical office buildings. By partnering with experienced operators, Diversified Healthcare Trust aims to generate stable, long-term cash flows through triple-net leases and percentage rent structures tailored to each property type.

The company’s portfolio spans multiple states and encompasses a mix of single-tenant and multi-tenant properties.